The Drugs Controller General of India (DCGI) has cleared applications from five pharmaceutical companies to manufacture anti-fungal drug Amphotericin B, used to treat mucormycosis or black fungus.
The subject expert committee (SEC) of the health ministry on Wednesday had given its nod to proposals from drug makers to boost the availability of Amphotericin B.
These developments come amid fast spread of the disease in various states and shortage of drugs to treat them. The government, however, hopes the fresh approvals and imports will help end the drug shortage soon.
Rajasthan has already declared mucormycosis or black fungus
The subject expert committee (SEC) of the health ministry on Wednesday had given its nod to proposals from drug makers to boost the availability of Amphotericin B.
These developments come amid fast spread of the disease in various states and shortage of drugs to treat them. The government, however, hopes the fresh approvals and imports will help end the drug shortage soon.
Rajasthan has already declared mucormycosis or black fungus